Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled study
Haak, T., Meinicke, T., Jones, R., Weber, S., Eynatten, M. von, Woerle, H.-J.
Published in Diabetes, obesity & metabolism (01.06.2012)
Published in Diabetes, obesity & metabolism (01.06.2012)
Get full text
Journal Article
Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study
Kawamori, R., Inagaki, N., Araki, E., Watada, H., Hayashi, N., Horie, Y., Sarashina, A., Gong, Y., von Eynatten, M., Woerle, H. J., Dugi, K. A.
Published in Diabetes, obesity & metabolism (01.04.2012)
Published in Diabetes, obesity & metabolism (01.04.2012)
Get full text
Journal Article
Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus
Schernthaner, G., Barnett, A. H., Emser, A., Patel, S., Troost, J., Woerle, H.-J., von Eynatten, M.
Published in Diabetes, obesity & metabolism (01.05.2012)
Published in Diabetes, obesity & metabolism (01.05.2012)
Get full text
Journal Article
Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged> or =65years
Schernthaner, G, Barnett, A H, Patel, S, Hehnke, U, von Eynatten, M, Woerle, H-J
Published in Diabetes, obesity & metabolism (01.11.2014)
Published in Diabetes, obesity & metabolism (01.11.2014)
Get full text
Journal Article
Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease
VON EYNATTEN, M, LEPPER, P. M, HUMPERT, P. M, LIU, D, LANG, K, BAUMANN, M, NAWROTH, P. P, BIERHAUS, A, DUGI, K. A, HEEMANN, U, ALLOLIO, B
Published in Diabetologia (01.09.2007)
Published in Diabetologia (01.09.2007)
Get full text
Journal Article
Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
Inzucchi, S. E., Nauck, M. A., Hehnke, U., Woerle, H.-J., von Eynatten, M., Henry, R. R.
Published in Diabetes, obesity & metabolism (01.09.2015)
Published in Diabetes, obesity & metabolism (01.09.2015)
Get full text
Journal Article
Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment
Groop, P.-H., Del Prato, S., Taskinen, M.-R., Owens, D. R., Gong, Y., Crowe, S., Patel, S., von Eynatten, M., Woerle, H.-J.
Published in Diabetes, obesity & metabolism (01.06.2014)
Published in Diabetes, obesity & metabolism (01.06.2014)
Get full text
Journal Article
Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial
Ross, S. A., Caballero, A. E., Del Prato, S., Gallwitz, B., Lewis-D'Agostino, D., Bailes, Z., Thiemann, S., Patel, S., Woerle, H.-J., von Eynatten, M.
Published in Diabetes, obesity & metabolism (01.02.2015)
Published in Diabetes, obesity & metabolism (01.02.2015)
Get full text
Journal Article
Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial
Gallwitz, B., Rosenstock, J., Patel, S., von Eynatten, M., Hehnke, U., Mehlburger, L., Dugi, K. A., Woerle, H.-J.
Published in Diabetes, obesity & metabolism (01.03.2015)
Published in Diabetes, obesity & metabolism (01.03.2015)
Get full text
Journal Article
Levels of three distinct p75 neurotrophin receptor forms found in human plasma are altered in type 2 diabetic patients
Humpert, P. M, Kopf, S, Djuric, Z, Laine, K, Korosoglou, G, Rudofsky, G. Jr, Hamann, A, Morcos, M, von Eynatten, M, Nawroth, P. P, Bierhaus, A
Published in Diabetologia (01.07.2007)
Published in Diabetologia (01.07.2007)
Get full text
Journal Article
Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged ≥ 65 years
Schernthaner, G., Barnett, A. H., Patel, S., Hehnke, U., von Eynatten, M., Woerle, H.-J.
Published in Diabetes, obesity & metabolism (01.11.2014)
Published in Diabetes, obesity & metabolism (01.11.2014)
Get full text
Journal Article
Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension
Barnett, A. H., Patel, S., Harper, R., Toorawa, R., Thiemann, S., von Eynatten, M., Woerle, H.-J.
Published in Diabetes, obesity & metabolism (01.12.2012)
Published in Diabetes, obesity & metabolism (01.12.2012)
Get full text
Journal Article
Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study
Haak, T., Meinicke, T., Jones, R., Weber, S., von Eynatten, M., Woerle, H.-J.
Published in International journal of clinical practice (Esher) (01.12.2013)
Published in International journal of clinical practice (Esher) (01.12.2013)
Get full text
Journal Article
Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA1c < 7% with no hypoglycaemia and no weight gain over 2 years
Gallwitz, B., Rosenstock, J., Emser, A., von Eynatten, M., Woerle, H.-J.
Published in International journal of clinical practice (Esher) (01.04.2013)
Published in International journal of clinical practice (Esher) (01.04.2013)
Get full text
Journal Article
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes
Araki, E., Kawamori, R., Inagaki, N., Watada, H., Hayashi, N., Horie, Y., Sarashina, A., Thiemann, S., von Eynatten, M., Dugi, K., Woerle, H.-J.
Published in Diabetes, obesity & metabolism (01.04.2013)
Published in Diabetes, obesity & metabolism (01.04.2013)
Get full text
Journal Article
Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study
Lepper, Philipp M, Ott, Sebastian, Nüesch, Eveline, von Eynatten, Maximilian, Schumann, Christian, Pletz, Mathias W, Mealing, Nicole M, Welte, Tobias, Bauer, Torsten T, Suttorp, Norbert, Jüni, Peter, Bals, Robert, Rohde, Gernot
Published in BMJ (Online) (29.05.2012)
Published in BMJ (Online) (29.05.2012)
Get full text
Journal Article
Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes
Von Eynatten, M., Baumann, M., Heemann, U., Zdunek, D., Hess, G., Nawroth, P. P., Bierhaus, A., Humpert, P. M.
Published in European journal of clinical investigation (01.02.2010)
Published in European journal of clinical investigation (01.02.2010)
Get full text
Journal Article
Urinary n-acetyl-beta-d-glucosaminidase excretion: an indicator of neuropathy in type 2 diabetes
Kopf, S, Oikonomou, D, Zdunek, D, von Eynatten, M, Hess, G, Nawroth, P P, Bierhaus, A, Humpert, P M
Published in Experimental and clinical endocrinology & diabetes (01.11.2013)
Published in Experimental and clinical endocrinology & diabetes (01.11.2013)
Get more information
Journal Article